Proline dehydrogenase (oxidase) in cancer

BioFactors

Volumn 38, Issue 6, 2012, Pages 398-406

  Liu, Wei ^a   Phang, James M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Metabolic stress; Oncogene; Proline dehydrogenase oxidase; Reactive oxygen species; Tumor suppressor

Indexed keywords

2 OXOGLUTARIC ACID; ADENOSINE TRIPHOSPHATE; HYPOXIA INDUCIBLE FACTOR; MICRORNA; MICRORNA 23B; MYC PROTEIN; OXIDOREDUCTASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROLINE; PROLINE DEHYDROGENASE; PROTEIN P53; PYRROLINE 5 CARBOXYLATE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID METABOLISM; APOPTOSIS; AUTOPHAGY; CANCER INHIBITION; CANCER SURVIVAL; CARCINOGENESIS; CATALYSIS; CELL CYCLE; CITRIC ACID CYCLE; CYTOSOL; ELECTRON TRANSPORT; ENZYME ACTIVITY; GLUCOSE DEPRIVATION; GLUCOSE METABOLISM; HUMAN; METABOLIC STRESS; MITOCHONDRION; NEOPLASM; NONHUMAN; ONCOGENE C MYC; OXYGEN CONSUMPTION; OXYGEN DEPRIVATION; PENTOSE PHOSPHATE CYCLE; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; UREA CYCLE;

ANIMALS; APOPTOSIS; AUTOPHAGY; HUMANS; MICRORNAS; NEOPLASMS; PPAR GAMMA; PROLINE; PROLINE OXIDASE; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84871240190     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1036     Document Type: Review

References (56)

1. Phang, J. M., Downing, S. J., Yeh, G. C., Smith, R. J., Williams, J. A., et al. (1982) Stimulation of the hexosemonophosphate-pentose pathway by pyrroline-5-carboxylate in cultured cells. J. Cell Physiol. 110, 255-261.
2. Yeh, G. C., Roth, E. F. Jr., Phang, J. M., Harris, S. C., Nagel, R. L., et al. (1984) The effect of pyrroline-5-carboxylic acid on nucleotide metabolism in erythrocytes from normal and glucose-6-phosphate dehydrogenase-deficient subjects. J. Biol. Chem. 259, 5454-5458.
3. Phang, J. M. (1985) The regulatory functions of proline and pyrroline-5-carboxylic acid. Curr. Top. Cell Regul. 25, 91-132.
4. Peng, Z., Lu, Q., and Verma, D. P. (1996) Reciprocal regulation of delta 1-pyrroline-5-carboxylate synthetase and proline dehydrogenase genes controls proline levels during and after osmotic stress in plants. Mol. Gen. Genet. 253, 334-341.
5. Schafer, I. A., Scriver, C. R., and Efron, M. L. (1962) Familial hyperprolinemia, cerebral dysfunction and renal anomalies occuring in a family with hereditary nephropathy and deafness. N. Engl. J. Med. 267, 51-60.
6. Phang, J. M., Hu, C. A., and Valle, D. (2001) Disorders of proline and hydroxyproline metabolism. In Metabolic and Molecular Bases of Inherited Disease. (Scriver, C. R., Beaudet, A. L., Sly, W. S., Valle, D., eds.). pp. 1821-1838, McGraw-Hill, New York.
7. Bender, H. U., Almashanu, S., Steel, G., Hu, C. A., Lin, W. W., et al. (2005) Functional consequences of PRODH missense mutations. Am. J. Hum. Genet. 76, 409-420.
8. Willis, A., Bender, H. U., Steel, G., and Valle, D. (2008) PRODH variants and risk for schizophrenia. Amino Acids 35, 673-679.
9. Phang, J. M., Liu, W., and Zabirnyk, O. (2010) Proline metabolism and microenvironmental stress. Annu. Rev. Nutr. 30, 441-463.
10. Phang, J. M. and Liu, W. (2012) Proline metabolism and cancer. Front Biosci. 17, 1835-1845.
11. Adams, E. and Frank, L. (1980) Metabolism of proline and the hydroxyprolines. Annu. Rev. Biochem. 49, 1005-1061.
12. Liu, Y., Borchert, G. L., Donald, S. P., Surazynski, A., Hu, C. A., et al. (2005) MnSOD inhibits proline oxidase-induced apoptosis in colorectal cancer cells. Carcinogenesis 26, 1335-1342.
13. Pandhare, J., Donald, S. P., Cooper, S. K., and Phang, J. M. (2009) Regulation and function of proline oxidase under nutrient stress. J. Cell Biochem. 107, 759-768.
14. Phang, J. M., Liu, W., Hancock, C., and Christian, K. J. (2012) The proline regulatory axis and cancer. Front Oncol. 2, 60.
15. Donald, S. P., Sun, X. Y., Hu, C. A., Yu, J., Mei, J. M., et al. (2001) Proline oxidase, encoded by p53-induced gene-6, catalyzes the generation of proline-dependent reactive oxygen species. Cancer Res. 61, 1810-1815.
16. Maxwell, S. A. and Rivera, A. (2003) Proline oxidase induces apoptosis in tumor cells, and its expression is frequently absent or reduced in renal carcinomas. J. Biol. Chem. 278, 9784-9789.
17. Pandhare, J., Cooper, S. K., and Phang, J. M. (2006) Proline oxidase, a proapoptotic gene, is induced by troglitazone: evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms. J. Biol. Chem. 281, 2044-2052.
18. Liu, Y., Borchert, G. L., Surazynski, A., Hu, C. A., and Phang, J. M. (2006) Proline oxidase activates both intrinsic and extrinsic pathways for apoptosis: the role of ROS/superoxides, NFAT and MEK/ERK signaling. Oncogene 25, 5640-5647.
19. Lu, M., Kwan, T., Yu, C., Chen, F., Freedman, B., et al. (2005) Peroxisome proliferator-activated receptor gamma agonists promote TRAIL-induced apoptosis by reducing survivin levels via cyclin D3 repression and cell cycle arrest. J. Biol. Chem. 280, 6742-6751.
20. Liu, Y., Borchert, G. L., Donald, S. P., Diwan, B. A., Anver, M., et al. (2009) Proline oxidase functions as a mitochondrial tumor suppressor in human cancers. Cancer Res. 69, 6414-6422.
21. Liu, Y., Borchert, G. L., Surazynski, A., and Phang, J. M. (2008) Proline oxidase, a p53-induced gene, targets COX-2/PGE2 signaling to induce apoptosis and inhibit tumor growth in colorectal cancers. Oncogene 27, 6729-6737.
22. Verma, A. (2006) Oxygen-sensing in tumors. Curr. Opin. Clin. Nutr. Metab. Care 9, 366-378.
23. Koivunen, P., Hirsila, M., Remes, A. M., Hassinen, I. E., Kivirikko, K. I., et al. (2007) Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF. J. Biol. Chem. 282, 4524-4532.
24. Liu, W., Zabirnyk, O., Wang, H., Shiao, Y. H., Nickerson, M. L., et al. (2010) miR-23b targets proline oxidase, a novel tumor suppressor protein in renal cancer. Oncogene 29, 4914-4924.
25. Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., and Vogelstein, B. (1997) A model for p53-induced apoptosis. Nature 389, 300-305.
26. Maxwell, S. A. and Kochevar, G. J. (2008) Identification of a p53-response element in the promoter of the proline oxidase gene. Biochem. Biophys. Res. Commun. 369, 308-313.
27. Rivera, A. and Maxwell, S. A. (2005) The p53-induced gene-6 (proline oxidase) mediates apoptosis through a calcineurin-dependent pathway. J. Biol. Chem. 280, 29346-29354.
28. Bensaad, K. and Vousden, K. H. (2005) Savior and slayer: the two faces of p53. Nat. Med. 11, 1278-1279.
29. Vousden, K. H. and Prives, C. (2009) Blinded by the light: the growing complexity of p53. Cell 137, 413-431.
30. Willson, T. M., Brown, P. J., Sternbach, D. D., and Henke, B. R. (2000) The PPARs: from orphan receptors to drug discovery. J. Med. Chem. 43, 527-550.
31. Phang, J. M., Pandhare, J., Zabirnyk, O., and Liu, Y. (2008) PPARgamma and proline oxidase in cancer. PPAR Res. 2008, 542694.
32. Robbins, G. T. and Nie, D. (2012) PPAR gamma, bioactive lipids, and cancer progression. Front Biosci. 17, 1816-1834.
33. Talbert, D. R., Allred, C. D., Zaytseva, Y. Y., and Kilgore, M. W. (2008) Transactivation of ERalpha by Rosiglitazone induces proliferation in breast cancer cells. Breast Cancer Res. Treat. 108, 23-33.
34. Zabirnyk, O., Liu, W., Khalil, S., Sharma, A., and Phang, J. M. (2010) Oxidized low-density lipoproteins upregulate proline oxidase to initiate ROS-dependent autophagy. Carcinogenesis 31, 446-454.
35. Govindarajan, R., Ratnasinghe, L., Simmons, D. L., Siegel, E. R., Midathada, M. V., et al. (2007) Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes. J. Clin. Oncol. 25, 1476-1481.
36. Kim, K. Y., Ahn, J. H., and Cheon, H. G. (2007) Apoptotic action of peroxisome proliferator-activated receptor-gamma activation in human non small-cell lung cancer is mediated via proline oxidase-induced reactive oxygen species formation. Mol. Pharmacol. 72, 674-685.
37. Wang, J., Lv, X., Shi, J., Hu, X., and Du, Y. (2011) Troglitazone induced apoptosis via PPARgamma activated POX-induced ROS formation in HT29 cells. Biomed. Environ. Sci. 24, 391-399.
38. Nagy, L., Tontonoz, P., Alvarez, J. G., Chen, H., and Evans, R. M. (1998) Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell. 93, 229-240.
39. Bartel, D. P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
40. Liu, W., Le, A., Hancock, C., Lane, A. N., Dang, C. V., et al. (2012) Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC. Proc. Natl. Acad. Sci. USA 109, 8983-8988.
41. Xu, H. J., Quinlan, D. C., Davidson, A. G., Hu, S. X., Summers, C. L., et al. (1994) Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma. J. Natl. Cancer Inst. 86, 695-699.
42. Zarse, K., Schmeisser, S., Groth, M., Priebe, S., Beuster, G., et al. (2012) Impaired insulin/IGF1 signaling extends life span by promoting mitochondrial L-proline catabolism to induce a transient ROS signal. Cell Metab. 15, 451-465.
43. Catchpole, G., Platzer, A., Weikert, C., Kempkensteffen, C., Johannsen, M., et al. (2009) Metabolic profiling reveals key metabolic features of renal cell carcinoma. J. Cell Mol. Med. 15, 109-118.
44. Hirayama, A., Kami, K., Sugimoto, M., Sugawara, M., Toki, N., et al. (2009) Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res. 69, 4918-4925.
45. Deryugina, E. I. and Quigley, J. P. (2006) Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 25, 9-34.
46. Kakkad, S. M., Solaiyappan, M., O'rourke, B., Stasinopoulos, I., Ackerstaff, E., et al. (2010) Hypoxic tumor microenvironments reduce collagen I fiber density. Neoplasia 12, 608-617.
47. Phang, J. M., Downing, S. J., and Yeh, G. C. (1980) Linkage of the HMP pathway to ATP generation by the proline cycle. Biochem. Biophys. Res. Commun. 93, 462-470.
48. Gordon, G., Mackow, M. C., and Levy, H. R. (1995) On the mechanism of interaction of steroids with human glucose 6-phosphate dehydrogenase. Arch. Biochem. Biophys. 318, 25-29.
49. Phang, J. M., Donald, S. P., Pandhare, J., and Liu, Y. (2008) The metabolism of proline, a stress substrate, modulates carcinogenic pathways. Amino Acids 35, 681-690.
50. Reiling, J. H. and Sabatini, D. M. (2006) Stress and mTORture signaling. Oncogene 25, 6373-6383.
51. Sengupta, S., Peterson, T. R., and Sabatini, D. M. (2010) Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol. Cell 40, 310-322.
52. Liu, W., Glunde, K., Bhujwalla, Z. M., Raman, V., Sharma, A., et al. Proline oxidase promotes tumor cell survival in hypoxic tumor microenvironments. Cancer Res., 72, 3677-3686.
53. Tontonoz, P., Nagy, L., Alvarez, J. G., Thomazy, V. A., and Evans, R. M. (1998) PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93, 241-252.
54. Suzuki, K., Ito, Y., Wakai, K., Kawado, M., Hashimoto, S., et al. (2004) Serum oxidized low-density lipoprotein levels and risk of colorectal cancer: a case-control study nested in the Japan Collaborative Cohort Study. Cancer Epidemiol. Biomarkers Prev. 13, 1781-1787.
55. Delimaris, I., Faviou, E., Antonakos, G., Stathopoulou, E., Zachari, A., et al. (2007) Oxidized LDL, serum oxidizability and serum lipid levels in patients with breast or ovarian cancer. Clin. Biochem. 40, 1129-1134.
56. Cao, Y. and Klionsky, D. J. (2007) Physiological functions of Atg6/Beclin 1: a unique autophagy-related protein. Cell Res. 17, 839-849.